GB1054698A - - Google Patents

Info

Publication number
GB1054698A
GB1054698A GB1054698DA GB1054698A GB 1054698 A GB1054698 A GB 1054698A GB 1054698D A GB1054698D A GB 1054698DA GB 1054698 A GB1054698 A GB 1054698A
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical composition
acid
ascorbic acid
salt
cackets
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Publication of GB1054698A publication Critical patent/GB1054698A/en
Active legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004Monosaccharides having only carbon, hydrogen and oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/375Ascorbic acid, i.e. vitamin C; Salts thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB1054698D 1964-12-04 Active GB1054698A (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4933064 1964-12-04

Publications (1)

Publication Number Publication Date
GB1054698A true GB1054698A (xx)

Family

ID=10451983

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1054698D Active GB1054698A (xx) 1964-12-04

Country Status (3)

Country Link
BE (1) BE673254A (xx)
FR (1) FR5013M (xx)
GB (1) GB1054698A (xx)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4414212A (en) * 1981-12-10 1983-11-08 Graham J. Naylor Method of treatment of pre-menstrual syndrome
US4704352A (en) * 1985-06-25 1987-11-03 Baxter Travenol Laboratories, Inc. L-ascorbate-2-phosphate salts in blood cell storage
WO1999053921A1 (en) * 1998-04-17 1999-10-28 Sigma-Tau Healthscience S.P.A. Composition comprising l-carnitine or an alkanoyl l-carnitine and nadh and/or nadph
WO2015176848A1 (en) * 2014-05-21 2015-11-26 Bauer K H Self-drying dosage form with controllable drying time and drying rate

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4414212A (en) * 1981-12-10 1983-11-08 Graham J. Naylor Method of treatment of pre-menstrual syndrome
US4704352A (en) * 1985-06-25 1987-11-03 Baxter Travenol Laboratories, Inc. L-ascorbate-2-phosphate salts in blood cell storage
WO1999053921A1 (en) * 1998-04-17 1999-10-28 Sigma-Tau Healthscience S.P.A. Composition comprising l-carnitine or an alkanoyl l-carnitine and nadh and/or nadph
AU750645B2 (en) * 1998-04-17 2002-07-25 Sigma-Tau Healthscience S.P.A. Composition comprising L-carnitine or an alkanoyl L-carnitine and NADH and/or NADPH
WO2015176848A1 (en) * 2014-05-21 2015-11-26 Bauer K H Self-drying dosage form with controllable drying time and drying rate

Also Published As

Publication number Publication date
FR5013M (xx) 1967-04-24
BE673254A (xx) 1966-06-03

Similar Documents

Publication Publication Date Title
IL36079A0 (en) 4-morpholino-thieno (3,2-d) pyrimidine derivatives,their production and pharmaceutical compositions containing them
OA04297A (fr) Ressort pour récipients destinés à recevoir et à délivrer un par un des articles, notamment des tablettes.
IL36018A0 (en) New 1,4-dihydropyridine derivatives,their production and pharmaceutical compositions containing them
GB1204580A (en) Pharmaceutical dosage forms
HU172709B (hu) Sposob poluchenija proizvodnykh difenil efirov, i gerbicidnykh kompozicijj soderzhahhikh ikh aktivnymiagentami
IL35729A0 (en) 2-(5-nitro-2-furyl)-thieno (3.2-d) pyrimidines,their preparation and pharmaceutical compositions containing them
GB975387A (en) Multivitamin compositions
GB1054698A (xx)
GB1247801A (en) Pharmaceutical compositions
IL47937A0 (en) Pharmaceutical compositions containing 6,8-diethyl-5-hydroxy-4-oxo-4h-1-benzopyran-2-carboxylic acid or a salt thereof
GB1356097A (en) Mineral salt preparation
DK123141B (da) Fremgangsmåde til stabilisering af et til oral indgift egnet farmaceutisk præparat, indeholdende en basisk dihydrodibenzazepin.
GB1346014A (en) Derivatives of alpha-ketoglutaric acid and their preparation
GB1202148A (en) Pharmaceutical compositions
ES255922A1 (es) Procedimiento para la preparaciën de la (cloro-2' amino-4' bencil)-1 bencil-4 piperacina
GB1289096A (xx)
GB1446584A (en) Agent for deodorising and influencing perspiration
IL34938A0 (en) Pharmaceutical compositions containing a 2,4-thiazolidine-dione-2 thiosemicarbazone derivatives
ES264510A1 (es) Metodo para la preparaciën de preparados de hierro de elevado poder de absorciën
ES362231A1 (es) Procedimiento de preparacion de un compuesto de accion hi- poglicemica.
IL30696A (en) Phenazine derivatives,processes for their preparation and pharmaceutical compositions containing them
GB1263839A (en) A novel aminoethanesulfonic acid
GB1336609A (en) Antismoking preparation
IL31294A0 (en) A new(hexafluoro-3,5-xylyl)-anthranilic acid and its salts,their preparation,and pharmaceutical compositions containing them
CA953715A (en) N(6)-(2,5-dimethylbenzyl)-2-chloroadenosine derivatives, process for their preparation and pharmaceutical compositions containing the same